Select Bibliography

 Search for any words:
Excel csv Word PDF RIS
  Filter by any of these (after searching):
      
Year
      
PubType
      
Endpoint
      
Analysis
      
Committee
      
Program
      
Meeting
NCTN
Funding
                            

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 2068 items

Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720 Google Scholar
,  ,  ... -    -  J. Clin. Oncol.   -  2008    
Abstract -  Secondary -  Primary -  Leukemia -  CALGB-10201 ,  CALGB-10502 ,  CALGB-10503 ,  CALGB-10603 ,  CALGB-19808 ,  CALGB-8525 ,  CALGB-8923 ,  CALGB-9022 ,  CALGB-9222 ,  CALGB-9420 ,  CALGB-9621 ,  CALGB-9720
Sole Trisomy 8 In Patients (pts) with De Novo Acute Myeloid Leukemia (AML) Is Associated with Age-Independent Poor Outcome That Is Modified by Molecular Markers and with Unique Gene- and Microrna (miR)-Signatures: a Cancer and Leukemia Group B (CALGB) Study Google Scholar
,  ,  ,  ... -    -  Blood   -  2010    
Abstract -  Secondary -  Primary -  Leuk Corr Sci -  C8525 ,  CALGB-10201 ,  CALGB-19808 ,  CALGB-20202 ,  CALGB-20502 ,  CALGB-8461 ,  CALGB-8923 ,  CALGB-9420 ,  CALGB-9621 ,  CALGB-9665 ,  CALGB-9720
Comparison of Clinical and Biologic Significance of WT1 Mutations in Populations of Older (>= 60 years y ) and Younger (< 60 y) Adult Patients (Pts) with Cytogenetically Normal (CN) De Novo Acute Myeloid Leukemia (AML): a Cancer and Leukemia Group B (CALGB) Study Google Scholar
,  ,  ,  ... -    -  Blood   -  2009    
Abstract -  Secondary-not-in-original -  Primary -  Correl Sci NOS -  C8525 ,  CALGB-10201 ,  CALGB-19808 ,  CALGB-20202 ,  CALGB-20502 ,  CALGB-8461 ,  CALGB-8923 ,  CALGB-9420 ,  CALGB-9621 ,  CALGB-9665 ,  CALGB-9720
CEBPA double mutations impact favorably on the outcome of older adults with wild-type NPM1 cytogenetically normal acute myeloid leukemia and are associated with distinct gene- and microRNA-expression patterns Google Scholar
,  ,  ,  ,  ... -    -  Haematologica   -  2010    
Abstract -  Secondary -  Primary -  Leuk Corr Sci -  C8525 ,  CALGB-10201 ,  CALGB-20202 ,  CALGB-20502 ,  CALGB-8461 ,  CALGB-8923 ,  CALGB-9420 ,  CALGB-9665 ,  CALGB-9720
Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study    QxMD    Google Scholar
,  ,  ... -    -  Haematologica   -  2011    
Manuscript -  Secondary -  Primary -  Leuk Corr Sci -  C8525 ,  CALGB-10201 ,  CALGB-19808 ,  CALGB-20202 ,  CALGB-20502 ,  CALGB-8461 ,  CALGB-8923 ,  CALGB-9420 ,  CALGB-9621 ,  CALGB-9665 ,  CALGB-9720